Home > Insider Trading > Filing (0001209191-21-063228)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087294	Cumberland Pharmaceuticals Inc	CPIX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1490829	James Jones	2525 West End Avenue Suite 950 Nashville TN 37203		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-10-01	42	$2.69	17,220	No	4	P	Direct
Common Stock	Acquisiton	2021-10-04	42	$2.87	17,262	No	4	P	Direct
Common Stock	Acquisiton	2021-10-05	42	$2.82	17,304	No	4	P	Direct
Common Stock	Acquisiton	2021-10-06	42	$2.76	17,346	No	4	P	Direct
Common Stock	Acquisiton	2021-10-07	42	$2.76	17,388	No	4	P	Direct
Common Stock	Acquisiton	2021-10-08	42	$2.84	17,430	No	4	P	Direct
Common Stock	Acquisiton	2021-10-11	42	$2.73	17,472	No	4	P	Direct
Common Stock	Acquisiton	2021-10-12	42	$2.71	17,514	No	4	P	Direct
Common Stock	Acquisiton	2021-10-13	42	$2.71	17,556	No	4	P	Direct
Common Stock	Acquisiton	2021-10-14	42	$2.81	17,598	No	4	P	Direct
Common Stock	Acquisiton	2021-10-15	42	$2.76	17,640	No	4	P	Direct
Common Stock	Acquisiton	2021-10-18	42	$2.75	17,682	No	4	P	Direct
Common Stock	Acquisiton	2021-10-19	42	$2.76	17,724	No	4	P	Direct
Common Stock	Acquisiton	2021-10-20	42	$2.63	17,766	No	4	P	Direct
Common Stock	Acquisiton	2021-10-21	42	$2.65	17,808	No	4	P	Direct
Common Stock	Acquisiton	2021-10-22	42	$2.66	17,850	No	4	P	Direct
Common Stock	Acquisiton	2021-10-25	42	$2.64	17,892	No	4	P	Direct
Common Stock	Acquisiton	2021-10-26	42	$2.64	17,934	No	4	P	Direct
Common Stock	Acquisiton	2021-10-27	42	$2.61	17,976	No	4	P	Direct
Common Stock	Acquisiton	2021-10-28	42	$2.61	18,018	No	4	P	Direct
Common Stock	Acquisiton	2021-10-29	42	$2.72	18,060	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.